General Biologicals Corp.(TW:4117)
NT$7.41-0.39 (-5.00%)
TW:4117
General Biologicals Corp. Revenue
NT$7.41
At close:-0.39 (-5.00%)
General Biologicals Corp. (4117) Revenue
General Biologicals Corp. Revenue
General Biologicals Corp. had a revenue of 155.22M in the quarter ending Jun 30, 2026, with 47.81%. This bring the company's revenue in the last twelve months to 260.23M, Increased 20.62%. In the fiscal year ending Dec 31, 2025, General Biologicals Corp. had annual revenue of 215.74M with -14.36% growth.
- Revenue (ttm)
- 260.23M
- Revenue Growth
- 3.52%
- P/S Ratio
- 2.56
- Revenue/Employee
- TWD 1,078,695
- Employees
- 200
- Market Cap
- TWD 552.43M
Revenue Chart
General Biologicals Corp. Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 215.74M | -36.19M | -14.36% |
| Dec 31, 2024 | 251.93M | -12.90M | -4.87% |
| Dec 31, 2023 | 264.82M | -105.63M | -28.51% |
| Dec 31, 2022 | 370.46M | -181.20M | -32.85% |
| Dec 31, 2021 | 551.66M | 75.79M | 15.93% |
| Dec 31, 2020 | 475.87M | 236.22M | 98.57% |
| Dec 31, 2019 | 239.65M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.